Use of intravenous Anti-RhD Immunoglobulin (RhIG) in the treatment of primary immune thrombocytop...

Real-world experience of anti-D immunoglobulin in immune thrombocytopenia

K Mishra, S Kumar, K Singh, A Jandial, R Sandal… - Annals of …, 2022 - Springer
In developing countries, anti-D has been used in immune thrombocytopenia (ITP) as a
cheaper alternative to human immunoglobulin. We aim to analyze the response and safety …
Save Cite Cited by 10 Related articles All 5 versions
[PDF] bsuedu.ru

[PDF][PDF] Thrombopoietin receptor agonists in pharmacotherapy of pediatric immune thrombocytopenia

OS Levchenkova, VV Vorobieva, VE Novikov… - 2023 - dspace.bsuedu.ru
Thrombopoietin receptor agonists in pharmacotherapy of pediatric immune
thrombocytopenia Page 1 Research Results in Pharmacology 9(1): 49-59 UDC: 616.155.294-053.2+615.015 …
Save Cite Related articles All 5 versions View as HTML